4//SEC Filing
Knifsend Robin 4
Accession 0001567619-19-012669
CIK 0001501989other
Filed
Jun 3, 8:00 PM ET
Accepted
Jun 4, 4:06 PM ET
Size
4.8 KB
Accession
0001567619-19-012669
Insider Transaction Report
Form 4
Knifsend Robin
Principal Accounting Officer
Transactions
- Award
Common Stock
2019-05-31$8.21/sh+1,812$14,878→ 2,791 total
Footnotes (1)
- [F1]1,812 shares were acquired pursuant to the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Documents
Issuer
CytomX Therapeutics, Inc.
CIK 0001501989
Entity typeother
Related Parties
1- filerCIK 0001777516
Filing Metadata
- Form type
- 4
- Filed
- Jun 3, 8:00 PM ET
- Accepted
- Jun 4, 4:06 PM ET
- Size
- 4.8 KB